Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fluenda
Here are the entities to be on the lookout for:
Seaside 88 LP – Private
Seaside 88 Advisers, LLC - Dennis O’Donnell, William J Ritger Officers
Seaside Capital Management, Inc – Dennis O’Donnell, Michael J Ritger
Officers
Seaside Capital Management, LLC – Denis O’Donnell Officer
Seaside Capital Advisors, LLC – William J Ritger Officer
Seaside Capital II, LLC, William J Ritger Officer
Seaside Analytics, LLC – William J Ritger Officer
Small Business Members of America, LLC - William Ritger, Robert Krohn Officer
Juno Research, Inc – William J Ritger Officer
Five-Star Lives, LLC – William J Ritger Officer
Zipzapmedia, LLC – William J Ritger Officer
It’s pretty obvious to me. On the $2.64 per share run up, total short shares went from the 260k neighborhood to over 2M. It is no coincidence that it occurred during the same period as the Seaside deal. Seaside has several related entities, like Seaside Capital Management Inc, where the principles of each company are either family or have a long history with each other. Looking back, after the deal, the timing of Inflationista and NNVClover to the board coincides with the peak and downturn of the NNVC PPS. NNVClover can claim he is shorting, and that he has millions, when in reality, he is probably working for those that do. It would not surprise me if he worked for one of the Seaside entities to make money on both ends of the deal. You have to have deep pockets to short 1M shares at $2.6. You also must have confidence (info) that that the stock is at a peak. I think Seaside had both. Shorts are covering on the solid buying at $1.0. That is probably frustrating to guys like NNVClover, but it is what it is. NNVClover can also claim he loves NNVC and is shorting it at the same time which fits this scenario.
NNVC should take 60 Minutes along to Africa and South America. That will dove tale nicely with the episode recently featuring Melinda Gates and the Gates foundation activities.
So what are the steps to PRV, and how long will it take? Plausible case: NNVC Dengue-cide PRV application September 2010, approval March 2011.
1) NNVC has identified 1 of 16 neglected tropical diseases, Dengue Fever, and a significant protection for it, Dr Harris et al. (February 2010, June 2010).
a. http://www.news-medical.net/news/20100217/NanoViricides-signs-research-and-development-agreement-with-Dr-Eva-Harrise28099s-laboratory-at-UC-Berkeley.aspx
b. http://www.drugs.com/clinical_trials/anti-dengue-nanoviricides-achieve-significant-protection-initial-vivo-studies-dengue-hemorrhagic-9667.html
2) NNVC is isolating Dengue-cides to find the most effective formula against all 4 strains of Dengue per “Dr Feelgood ” et al, IHUB September 2010.
a. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55072359
b. This was stated in the June 2010 NNVC PR as well. This study could be complete.
3) It has also been mentioned on IHUB that it is a natural for Dr. Harris to administer the final Dengue-cide at her clinics in South America as part of her Sustainable Sciences Institute out reach.
a. If done correctly, results could be used for FDA PRV approval.
b. PRV Application to FDA costs $1.542 M for fiscal 2011. It is not clear what the fee/cost was for FY 2010. If it were zero, that may have been incentive enough for NNVC to file for PRV Dengue-cide before September 30th 2010. That may also be a contributing reason for the additional shelf offering with Seaside 88.
c. http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2010/09/put-it-on-mr-underhills-bill-fda-sets-priority-review-voucer-redemption-fee-at-almost-46-million.html
4) Assuming the PRV application has been submitted before September 30th 2010, March 2011 may be when NNVC receives approval.
a. It appears that Novartis submitted their PRV application for Coartem malaria drug to the FDA in October or November 2008 and received approval in April 2009.
b. http://www.pharmalot.com/2008/11/novartis-and-the-fda-priority-review-voucher/
c. http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2009/04/fda-approves-coartem-with-priority-review-voucher-voucher-market-is-untested-and-unclear.html
5) Tox studies are required before submitting the NDA for PRV
a. http://www.essortment.com/all/fdadrugapprova_rrgy.htm
b. Since the June 2010 NNVC PR already discloses the fact that further refinement of the Dengue-cide had started, it may be that tox studies have already been initiated.
c. As has been mentioned by “Dr Feelgood” on IHUB, the test cycle for antivirals can be weeks given the fact that viruses are short lived.
d. Bottom line March 2011 could be a big month for NNVC.
Senate bill would encourage drugs targeting rare kids' diseases
Priority review vouchers (PRVs), as I've explained, are "golden tickets" that allow pharmaceutical companies to jump to the head of the FDA line. This ability is worth, conservatively, hundreds of millions of dollars. More importantly, these chits can be sold to Big Pharma. As I've told you before, one Big Pharma executive told me that an internal study from one of the biggest pharma coms valued the chits at about $380 million. NanoViricides is already on track to winning a dengue PRV.
http://thehill.com/blogs/healthwatch/prescription-drug-policy/113109-senate-bill-would-expedite-drugs-targeting-rare-kids-diseases
A group of bipartisan senators this week introduced legislation to entice drug makers to focus more intently on cures for uncommon children's diseases.
Sponsored by Sens. Sherrod Brown (D-Ohio), Sam Brownback (R-Kan.) and Al Franken (D-Minn.), the Creating Hope Act aims to solve a nagging problem inherent to the market-driven world of pharmaceutical manufacturing: how to encourage the creation of expensive-to-develop drugs that few patients need?
The lawmakers hope to do so by offering expedited FDA approval of potentially popular drugs to pharmaceutical companies that develop treatments for rare pediatric diseases. The idea is that the financial incentive associated with bringing "blockbuster" drugs to the market sooner will encourage companies to work harder researching the lesser needed treatments.
The proposal expands on a 2007 law that offers "priority review vouchers" to companies that develop new drugs for neglected tropical diseases. Drugs yielding vouchers, under the bill, must meet the definition of "rare" established by the Orphan Drug Act, and must not have previous approval from the FDA.
The bill would also prohibit companies from getting vouchers under the 2007 law for drugs already on the market abroad. Closing that loophole would force the companies to create new treatments, rather than simply bringing old ones to market in the U.S.
The National Institutes of Health estimates that there are more than 6,000 diseases qualifying as rare under the Orphan Drug Act, a vast majority of which get little or no drug company research money because the return on investment would be so small.
"We are falling woefully and inadequately short in our efforts to cure and treat rare and neglected pediatric diseases and conditions," Brown said in a statement announcing the bill.
Kids' healthcare advocates agree.
"This legislation aligns government and private sector interests and will be a major step forward in addressing the unmet needs of children with devastating illnesses, including life-threatening cancer," said Nancy Goodman, executive director of Kids v Cancer.
Everyone forgets ROI. Return On Investment. I am making the point about the effectiveness by which Nanoviricides Inc. invests the less than 10% of the $40M of public funding it has access to. If that leads to an IND trial, and Tox package for DengueCide, then it will be a fantastic investment. If it merely pays the salaries of those trying to find a viable business plan then, it will bust the company. The Docs know that. Most of the market knows that. That’s why the Docs have waited to pull the trigger. They have pulled the trigger. They are going for it.
Fear based personalities don’t get it. Fact based personalities get that NNVC is on the goal line ready to score and score quickly and often. That is the wild card. That drives the demand to have a piece of this company. Know one can stop it.
Anti-virals have a short timeline to trial outcome. This business model confounds the chartists, and the prognosticators because everyone knows in there heart of hearts that it doesn’t get any better than this for the gusher of all pharmaceuticals. Market psychology makes the charts, not the other way around.
Is there a way to know or find out how many shares Seaside has actually sold to date?
Avoid Mosquito Bites to Prevent Dengue Fever in Florida: Expert
Advice to cut risk includes using bug spray with DEET, eliminating still water sources
-- Robert PreidtFRIDAY, July 23 (HealthDay News) -- People planning to visit Florida should take measures to protect themselves against dengue fever by preventing mosquito bites, advises an expert.
For the first time in 75 years, the mosquito-borne disease has reappeared in parts of Florida, and dozens of cases have been reported so far this year. Dengue fever affects 100 million people worldwide every year.
"Dengue fever is transmitted by Aedes mosquitoes, which are present in the U.S. These are domesticated mosquitoes that breed in still waters around homes, such as potted plant dishes, vases, bird baths, etc. Draining these water sources is an important measure to prevent infection," Dr. Bert Lopansri, medical director of the Loyola University Health System International Medicine and Traveler's Immunization Clinic, said in a university news release.
Because the disease can't be transmitted from person to person, a few simple measures can protect you from infection, he suggests.
"Mosquitoes that transmit dengue feed during the day, mostly during the early morning and late afternoon. Protective measures include wearing clothing that protects all of your body from bites, if at all possible," Lopansri said. "Also be sure to use mosquito repellant with effective chemicals such as DEET."
Overall, visitors to the Sunshine State are at low risk, he added.
"The situation in Florida is evolving and it seems to be localized in South Florida at this time," Lopansri said. "For those who are a little concerned about it, just do the things you would normally do to avoid mosquitoes, and then have a good time."
To help recognize the signs of dengue fever, the U.S. National Institute of Allergy and Infectious Diseases provides a list of symptoms. They say classic dengue fever starts with a high fever (up to 105 degrees Fahrenheit) within several days of being bitten by an infected mosquito. Other symptoms include severe headache, pain behind the eyes, severe joint and muscle aches, nausea, vomiting and rash.
More information
The U.S. Centers for Disease Control and Prevention has more about dengue fever.
SOURCE: Loyola University, news release, July 21, 2010
http://health.msn.com/health-topics/infectious-diseases/articlepage.aspx?cp-documentid=100261531
'Indescribable, crazy pain': Surviving dengue feverBy Amanda Gardner, Health.com
July 22, 2010 10:46 a.m. EDT
Since Potter's diagnosis, the CDC and health officials in Florida have confirmed at least 28 cases of the fever in Key West.STORY HIGHLIGHTS
Dengue fever is a viral disease native to the tropics but very rare in the continental U.S.
Symptoms include nausea, fever, debilitating headaches, eye pain, and bloody urine
A rash in the form of small red dots is what caused Potter's doctor to suspect Dengue Fever
Dengue fever is transmitted by a mosquito found in warm climates
RELATED TOPICS
Centers for Disease Control and Prevention
Emergency Medicine
Key West
Public Health Policy
Contagious and Infectious Diseases
(Health.com) -- Jeanette Potter was in the Atlanta airport when she started to feel a bit off.
"I thought I had the flu, but it was a heavier kind of flu," says Potter, 34, who had been flying home to Rochester, New York, after a weeklong vacation in Key West. "I was achy. I had a headache. I was kind of disoriented."
Her symptoms weren't from the flu, as it turns out. They were the early signs of dengue fever, a viral disease native to the tropics but incredibly rare in the continental U.S. -- so rare that it took two weeks, three visits to the doctor, and one trip to the emergency room before experts at the Centers for Disease Control and Prevention finally identified what ailed her, in September 2009.
Potter is the first known victim of a dengue fever outbreak that has since led to more than two dozen confirmed cases in Key West, and, health officials fear, may be headed north.
Health.com: America's healthiest beach and lake getaways
Also known as "breakbone fever" because of the shattering pain it causes, dengue fever is transmitted by a mosquito found in warm climates, and is not contagious. (Potter got several mosquito bites in Key West.) People often contract dengue fever without realizing they have it, but in some cases it can lead to dengue hemorrhagic fever, a severe form of the illness which causes internal bleeding and can lead to shock and even death.
A day after returning from her trip, Potter felt much worse. Her aches were joined by chills, a low-grade fever, and a pounding headache that Tylenol and Advil were powerless to stop.
"My head hurt so bad that I wouldn't wish it on my worst enemy," she recalls. "It hurt to move my eyes. I was getting to the point where I couldn't function mentally. I was in a fog."
Oddly, Potter also noticed that her urine was discolored. She suspected a urinary tract infection, as did her doctor, Adriane Trout, M.D., a family physician at Rochester General Hospital, who prescribed antibiotics.
Health.com: Your healthy travel planner
Two days later, Potter returned to Trout's office and failed an equilibrium test (like the one used in field sobriety tests). Trout sent her to the emergency room. The ER physicians originally suspected spinal meningitis, but after eight hours of tests -- including a spinal tap and a CT scan, both negative -- they hadn't confirmed a diagnosis.
So Potter went home. "I was down and out in my bed for eight days straight," she says. "Your bones just hurt. That's why it's called breakbone disease. It's indescribable. I can't even articulate the crazy pain that you're in. You feel like you're heavy and out of your body."
When Potter failed to improve, Trout began to suspect dengue fever -- even though she had never before encountered the illness.
"What tipped me off was she had a petechiae rash," Trout says, referring to a series of small red dots on the skin caused by broken capillaries (a form of internal bleeding). "And her [blood] platelets were low, and when I looked at her blood cells, one of the markers for a viral infection was high."
After consulting with a colleague who's an expert on infectious diseases, Trout arranged for a sample of Potter's blood to be sent to the CDC office in Puerto Rico to be tested for dengue fever.
Health.com: Travel health: What to do if you get ill
The tests came back positive, and with that Potter became the first confirmed case of the fever acquired in Florida since 1934.
Once widespread in the Western hemisphere (including the Southern U.S.), dengue fever was largely eradicated in the 1960s after the carrier mosquitoes were targeted with the pesticide DDT. The disease slowly rebounded after those efforts were discontinued, however, and while it generally stays confined to the tropics now, a handful of small, scattered outbreaks have occurred in the U.S. along the Mexican border over the past 30 years, according to the CDC.
Since Potter's diagnosis, the CDC and health officials in Florida have confirmed at least 28 cases of the fever in Key West. More than 1,000 other residents -- roughly 5 percent of the local population -- may have been exposed without getting ill, according to a CDC report released last week.
A suspected case in Miami reported last Thursday turned out to be a false alarm, but health officials are worried that the fever may spread northward. "We're concerned that if dengue gains a foothold in Key West, it will travel to other southern cities where the mosquito that transmits dengue is present, like Miami," the chief of the dengue branch at the CDC, Harold Margolis, said in a statement that accompanied the report.
Health: Beat the top summer health hazards
The symptoms Potter experienced were textbook. Often mistaken for the flu, dengue symptoms include nausea, fever, debilitating headaches, eye pain, and bloody urine. The rash noticed by Trout is a telltale sign of dengue hemorrhagic fever.
Rick Branch, 41, a U.S. Navy officer stationed in Key West, was among the first cases to be confirmed after Potter. He started feeling sick on the Monday after Easter Sunday earlier this year.
"It felt kind of like a hangover -- though I wasn't drinking the night before," he says. "I had a foggy head. I was a little bit tired."
Three hours later, Branch was freezing cold and had a fever. By Tuesday his joints were getting sore, and by Wednesday the pain was excruciating. "I could barely walk straight because the joints hurt so bad," he recalls. "They don't call it breaking-bones for nothing."
He had also developed a rash, and by Thursday his gums were bleeding. "I was hemorrhaging," he says.
Although Branch and his wife had looked up his symptoms on the Internet and began to suspect dengue fever, it wasn't until he was flown to Miami and saw four doctors there that dengue fever was seriously considered.
Health.com: Stay safe at the beach
Most cases of dengue fever resolve on their own within a week or two, and there's no treatment for the disease except supportive care. Even Branch and Potter -- who had relatively serious cases -- got confirmation that they'd had dengue only after they had fully recovered. Potter suffered through eight days of agony before her pain stopped and she slowly started to feel normal again.
The CDC and the local department of health in Key West are advising people traveling to the area to use mosquito repellent and wear long sleeves and pants. Residents should also remove any standing water around their homes to keep the mosquito population down, officials said. (Branch has already done so.)
Now that Potter and Branch have developed antibodies to the virus, they run the risk of an even worse reaction if they're ever infected again.
Potter, for one, isn't taking any chances. "I will never go to Key West again, certainly," she says. "No way."
http://www.cnn.com/2010/HEALTH/07/22/dengue.fever/
Dengue spreading to central Florida
http://www.wesh.com/health/24343521/detail.html
Dengue Fever Showing Up In Central Florida
Officials Trying To Prevent Spread To Local Mosquito Population
POSTED: 5:18 pm EDT July 21, 2010
UPDATED: 5:46 pm EDT July 21, 2010
Comments (3)ORANGE COUNTY, Fla. --
Dengue fever has infected a handful of people in Central Florida, health officials said.
“This is not a regular flu virus that you get, you feel a lot worse,” said Dr. Todd Husty.
“You get a real great fever, a horrible fever; it's called ‘break bone fever.’ You feel like your bones are breaking, but it's really joint pain,” Husty said.
Health officials said more than a dozen people have picked up the virus from Mosquitoes in the Keys.
More than 30 more across the state of Florida have the fever after picking it up out of the country.
Signs And Symptoms Of Dengue Fever
Mosquitoes in Central Florida do not carry Dengue, but they could if people are not careful, local doctors said.
Mosquito control experts are treating areas near where three Orange County people have Dengue. While the patients caught the fever somewhere else, if they get bitten by mosquitoes the virus could get into the local mosquito population.
“There's a possibility that you've produced enough virus for our local mosquitoes to pick it up,” said Dr. Tom Breaud with Orange County Mosquito Control.
Doctors say anyone with Dengue should stay inside, away from mosquitoes.
While most mosquitoes bite at dawn and dusk, insects carrying Dengue have a different pattern.
“The mosquitoes that transmit Dengue to us bite during the day,” said Breaud.
Bring it !
If you want to save lives you declare HIVcide an orphan drug status or FDA fast track. Put HIVcide in the midst of the most desperate cases and see what happens. Bring it on !
Nano-medicine or bio-pharma is the new economy.
If I may digress, in each American recession a new technology pulled us out. After Reagan was elected, PC’s increased productivity across the board. After Clinton was elected, the dot-coms captured the internet business model.
Today, we find our country in another economic morass. I assert that bio-pharma on the nano-scale will be the new wave of technology that pulls our nation out of the mire. It’s a mix of technology, no doubt. But science is finally concquring the nano level of biology. It dawns a new era of life as we know it. Miracle drugs that cure diseases that were normally a death sentence or a miserable existence will be abolished in our generation. We the people may not perceive the transition, but it is here. It is upon us, and we need to act.
We may have a lot of problems in this world, but we have hope. We have hope in the brilliant minds working on otherwise insoluble problems producing incredible results with today’s technology. Do not despise the days of small beginnings. Let us not dwell on the impossible but the hope of things to small to see. It is the essence of life itself.
Awesome! My scientific nature just soaks this in. The video is very well done. The British narration is silky smooth. I love the cellular logic conjecture near the end. That is the great puzzle of stem cells. How do they know?
Videos are the new power point.
Exactly.
I have know way of knowing how much it costs. I was fine with this video right up to the 4 minute mark. I think any new drug that messes with my genes would be a risk. I would have no problem being a test subject of Nanoviricides since it only attacks the virus. That is nobel prize worthy.
An updated website means nothing. That might have mean't something in 2000, but not today. This is not a dot.com company.
Something like this:
I believe I have seen this before on this board, but recent break throughs by NNVC are the same order of this video. The scientists behind the RNAi discovery received the Nobel Prize. IMHO, so should Dr(s). Diwan and Seymour.
http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html
Time for NNVC to go viral!
Why wait for the news media to pick up on this breakthrough technology. Tape a briefing or make a video with animation and narration and post it on youtube. Then stand back. The world will get it.
Happy 4th !
Agreed
It does bring up an interesting postulate. What price would it take to buy out NNVC and Theracour?
$20B would be about right. That would put NNVC PPS around $100 per share and with enough to buy out Theracour.
Everyone has their price. It would probably get NNVC drugs to market quicker.
Notwithstanding that Dr Seymour cannot say yes.
$150 million to fight dengue fever, malaria and malnutrition in Mexico and Central America under the 2015 Meso-American Health Initiative (http://blog.taragana.com/health/2010/06/14/bill-gates-carlos-slim-announce-150-million-health-donation-for-mexico-central-america-24172/).
The fact that it is referenced in the PR leads me to be believe, there is already a connection to the Initiative and NNVC. What would be the best way for NNVC to use the funding to save lives and human suffering the quickest?
AMEX up-listing: Good news either way you look at it.
– “To wit, they are currently working on paperwork and filing requirements for an up-listing to the AMEX exchange”.
One of the first items discussed indicating a high priority for the company and management thrusts.
At first, I read it as they have not formally filed the paperwork for up-listing to the AMEX. That may be true, in which case I wonder if they have to stay above $2.00 for 10 days again? That may mean another run is around the corner.
If the paperwork is already filed, then up-listing might be around the corner.
This is it. We are up listing. We are going to the top like Yahoo and Google. It’s rare, but the market gets it.
The truth will be a matter of record shortly. Given that the PPS keeps going up on no news, with record volume, can only mean information is spreading by word of mouth to big investors. The bank of, yet, unreported news, which will be significant, is the carrot for the big investors. They know there is big news coming, the Dr’s know it, there is no need to pump the stock. It is fate de compli.
Just the prospect of "deep pockets" changes the bargaining of position of NNVC with Big Pharmas. They can always "buy in" to make a profit on both ends.
Of course, you are right ! The MMs hear the freight train coming.
One more step up will make this the most beautiful chart you could ask for. I can think of a half dozen PRs that would continue the pattern. There's always a dip right before a big step for some reason...
Thanks for the perspective.
Short interest has quadrupled over the last 30 days. That’s some big money betting on the dark side. Maybe a short a squeeze is around the corner?
Date
Short Interest % Change
Apr 15, 2010 1,767,955 82.18
Mar 31, 2010 970,457 144.91
Mar 15, 2010 396,253 42.35
Feb 26, 2010 278,373 7.24
http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=nnvc
Good for U.
I'm not going any where. I'm in for the long haul.
So you seem to be letting us down slowly. It’s interesting how a few of you seem to know what’s ahead but you have to couch it in possibilities, like going down to $1.60 is somehow a good thing.
If I were to take the cynical view, I would say your mission was to help keep the PPS above $2 to get listed to the Amex. That was a noble mission but you seem to be out of air. Given the numerous off topic posts like “Papaya Leaf” or “the NNV Web site banter”, I would conclude that you folks are temporarily between jobs.
Here are some useful tasks for you to work on:
1) Discuss the significance of up listing from the OTC. This has been discussed but the info is scattered. What are the key price break points, etc. How does that change how the stock is traded. Would there be less price manipulation?
2) Can you tell us if the up-listing paper work has been filed? That should be a matter of record, no?
3) What do you think would be the best scenario for announcing block buster news, for example, would it be better for the PPS to wait for up-listing then put out the news?
4) What was briefed by our NNVC leadership at the Biotechnology Association on 4/19?
5) I think I read on one of the posts that NNVC would provide HIVCide to patients terminally ill with AIDS in the Africa. That is very intriguing. First of all, is it real? And, second, if it is real, could the data be used to pre-IND filing for HIVCide?
6) No news Monday based on my take, otherwise you would be speculating about it and the PPS would have spiked near the end of Friday.
Capisce?
Call me stupid or crazy, it’s a reasonable question. Not everyone is an expert. I think people could benefit from a fundamental exchange of basic buying and selling strategy on this stock. The market is betting the stock goes up due to the promise of going to the Amex and all the things that NNVC has going for it. I belive we are in the era of the bio-tech and NNVC will be the example. No one knows the future, but there is good reason to believe the company and the stock will go to the next level once it is out of the OTC exchange. Who do you trust, the market or anonymous posters?
Of course, we all know it’s a bet. I can see a short interest play, that for the short term, that takes advantage of the excitement and shorts the stock, only to buys it back in at $2. No one wants to be out when this one takes off. Possibly other investors are more desperate and are under water on their short interest and would like to see the stock not make the $2 for 10 days criteria, which would undoubtedly cause a stock price disappointment until the next run up. Of course, I’m betting that we make it to the Amex and its onward and upward.
Really? I can't see how people will make money that way. There has been a lot of volume (10s of millions) put in this stock lately. I would like to hear why people would buy so much stock knowing that it will go below $2.
Thanks for your fact checks Doc.
You are the backbone of this board. I got my data from a previous post and wanted to re-emphasize the point. And for the record, I am long on NNVC. The shorts are a dying breed on this stock.
Just for the record, I am a guy. I chose my call name from a quote from an old Michael Keaton movie "Night Shift".
See you in Hawaii.
Patents, Patents, Patents
For bio-tech companies, it’s all about patents. I believe the recent run up is due, in part, to the latest health care bill that extends the life of revenue for patented, FDA approved, drugs. Under recently passed health care bill, there are provisions for bio-tech companies, like NanoViricides (NNVC) that have exclusive rights to patents or have outright patents for new drug pipelines that now have 2 ½ times more time (12 years Vs 5 years) to sell their product before generic competition starts. Time = Money.
NNVC has the perfect business model for the new healthcare bill. At a minimum, the value of NNVC was multiplied by 2.5. Multiply that by the number of viruses NNVC attacks (HIV, Type A Flu, Herpes Simplex 1 and 2, EKC, Rabbies, Dengue Fever, Ebola,). Let’s see, 9x 2.5x1.0 PPS >= $20. That’s without new any new deals.
That’s just simplistic math. There is some real money behind this run up…..
A cure for Herpes alone would be reason enough to surge to $20 - $50 a share. And, it is real. NNVC has the solution. I would think a Herpes creme could hit the market much quicker than any of the other NNVC antivirals.
We are going to the AMEX.
Don't you get it? The stock will be well above $3 soon, and the NNVC officers deserve to get rich. When they get rich, so do we. Is it that hard to see?
This reply deserves a sticky note.
Doc, I know you are modest, and the moderator, but this thread must be held high!
Just profit taking before a 3 day weekend.
One wave in an infinite series......
Provocative! Which is more international?